Elecoglipron
Elecoglipron
AstraZeneca · Phase 3 · Recruiting · Enrollment 351
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Arm 1 - Dose 1 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Arm 2 - Dose 2 | Obesity or overweight | n/r | n/r | n/r | n/r |
| Arm 3 - Placebo | Obesity or overweight | n/r | n/r | n/r | n/r |